missing translation for 'onlineSavingsMsg'
Learn More

CD99 Monoclonal Antibody (OTI1E7), TrueMAB™, OriGene

Mouse Monoclonal Antibody

Brand:  Origene Technologies TA800823

Encompass_Preferred

 View more versions of this product

Product Code. 17599012

  • € 540.87 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD99 (E2, MIC2) is a transmembrane glycoprotein that is involved in regulation of T cell addhesive properties and programmed cell death distinct from typical apoptosis course. CD99 roles are specific to certain stages of T cell differentiation such as corticothymocytes. CD99R isoform expression is restricted in the haematopoietic system to T, NK and myeloid cells.
Specifications

Specifications

CD99
Monoclonal
1 mg/mL
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
P14209
CD99
Full length human recombit protein of human CD99 produced in HEK293T cell.
100 μL
Primary
Human
Antibody
IgG1
Western Blot
OTI1E7
Unconjugated
CD99
HBA71, MIC2, MIC2X, MIC2Y, MSK5X
Mouse
Affinity Chromatography
RUO
4267
-20° C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.